AMPLY Discovery

AMPLY's CEO and glorious leader Ben Thomas (AKA Captain Awesome) is presenting next week at the #BioTrinity event in London on AMPLY's platform for biologic drug discovery. 💉 💡 All the cool kids are going. So if you don't have a ticket you probably aren't cool (sorry) 😎 Dermot Tierney Anne Dornan Stuart Gaffikin Jurnorain Gani Mark Beards https://lnkd.in/eCVnnWGj

AMPLY Discovery's recent wins in projects for AML and MDR-TB are still making the news! https://lnkd.in/esaBHSEn

AMPLY Discovery today annouced fresh grant funding for two of our pillar AI-driven drug disovery programmes - one focused on RNAi thereapies in cancer and the other focused on chronic and MDR lung infections. 2024 is set to be an important year for AMPLY as we accelerate these programmes and progress our full seed round with the support for new and existing investors. Ben Thomas Mark Beards Anne Dornan Stuart Gaffikin Daniel Pfeil Tricia Martínez-Saab Clarendon Fund Managers QUBIS Ltd Techstars Oisin Lappin Paul Reavey Chris Creevey Jurnorain Gani Peter Alexander David Moore Queen's University Belfast Gary Davidson #AI #AIDD https://lnkd.in/eTy9ivGS

We are honoured to be featured in the latest edition of the QUBIS Ltd Newsletter! Thanks for including us!

Explain the AMPLY Discovery platform to a non-scientist! Dr Ben Thomas describes how the AMPLY Discovery technology uses AI to speed up the process of finding new effective ways to kill disease threats. Bacterial infections could kill 10 million a year by 2050, so we need faster ways to develop new drugs. AMPLY Discovery is at the forefront of groundbreaking new technologies, combining AI, genomics and synthetic biology. Read our carousel to understand more! #amplydiscovery #ai #drugdiscovery #startup

AMPLY Discovery will be one of the leading NI-based start ups pitching at the Deep tech Summit in Belfast on 16th November. We look forward to catching up with friends and talking about our drug discovery programmes with investors. If you want to catch up, or fancy a nice night out in Belfast you can register to attend. Anne Dornan Dr. Cecilia Hegarty Paul Donachy QUBIS Ltd Brian McCaul https://lnkd.in/eUGESxVT

AMPLY Discovery were one of the companies that attended this year's Catalyst Inbound Investors event, which has become a key date in the calendar for all early stage biotechs in Northern Ireland who are raising capital. AMPLY will be raising again in the coming year to support continied development of our AI driven drug discovery platform. Great to catch up with so many friends from the ecosystem and as usual Queen's University Belfast and Ulster University spin outs were well represented! Dermot Tierney Mark Beards Ben Thomas Chris Creevey Anne Dornan Oisin Lappin Stuart Gaffikin

We are thrilled to share that AMPLY Discovery has been selected as one of 12 “exceptional AI startups”, to participate in the Techstars Chicago, powered by J.P. Morgan program. This accelerator is for early-stage companies that use Artificial Intelligence to address global problems, scale businesses, and design new business models. We will have the chance to work alongside some of the brightest minds, receive world-class mentorship, and access invaluable resources to accelerate the growth of Amply Discovery. Here’s a comment from Tricia Martínez-Saab, Managing Director of Techstars. “Artificial Intelligence is revolutionary technology that can be used as a tool to fight some of our greatest challenges. Now more than ever we need novel innovative out of the box solutions that can move the needle. Our 12 portfolio companies for Techstars Chicago powered by J.P. Morgan are pushing the boundaries on what is possible with Artificial Intelligence.” We look forward to sharing our progress, insights, and learnings along the way. Please feel free to reach out if you'd like to connect or collaborate! #AI #syntheticbiology #StartUp #AcceleratorProgram